Atea closes late-stage trial for COVID-19 drug to focus on use as a combination therapy
December 14 2021 - 5:23PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Apr 2023 to Apr 2024